Article: Introduction of a non-ported peripheral intravenous catheter with multi-use blood control septum offers improvements in the overall efficiency of the procedure and is clinically well accepted Journal: International Journal of Healthcare Technology and Management (IJHTM) 2016 Vol.15 No.3 pp.177 - 193 Abstract: Financial challenges that the National Health Service (NHS), England, faces may jeopardise its future. This study evaluated the direct cost of using two different safety peripheral intravenous cannulae (SPIVC) with and without a blood control septum, including the cost of device and clinician time. Observation of 103 cannulations demonstrated a 54 second (29%) time reduction per cannulation with the non-ported SPIVC with multi-use blood control septum (Introcan Safety® 3 B Braun), compared to the standard ported SPIVC (Vasofix® Safety B Braun) (P < 0.05). The direct cost analysis, including clinician time, demonstrated that the introduction of SPIVC with multi-use blood control septum could offer time efficiency savings equivalent to a reduction in average cannulation costs by 25%. 82% of users perceived the insertion of SPIVC with multi-use blood control septum to be easy to use; 82% would choose to use it in clinical practice. Inderscience Publishers - linking academia, business and industry through research

Title: Introduction of a non-ported peripheral intravenous catheter with multi-use blood control septum offers improvements in the overall efficiency of the procedure and is clinically well accepted

Authors: Dawn Michelle Cooper; Malcolm David Whitfield; David Newton; Joseph Chiarella; Katarzyna Karolina Machaczek

Addresses: Centre for Health Social Care, Faculty of Health and Wellbeing, Sheffield Hallam University, Sheffield, S10 2BP, UK ' Centre for Health Social Care, Faculty of Health and Wellbeing, Sheffield Hallam University, Sheffield, S10 2BP, UK ' Central Procurement, Nottingham University Hospitals NHS Trust, Nottingham, NG5 1PB, UK ' Accident and Emergency Department, Queens Medical Centre, Nottingham University Hospital NHS Trust, Nottingham, NG7 2UH, UK ' Centre for Health Social Care, Faculty of Health and Wellbeing, Sheffield Hallam University, Sheffield, S10 2BP, UK

Abstract: Financial challenges that the National Health Service (NHS), England, faces may jeopardise its future. This study evaluated the direct cost of using two different safety peripheral intravenous cannulae (SPIVC) with and without a blood control septum, including the cost of device and clinician time. Observation of 103 cannulations demonstrated a 54 second (29%) time reduction per cannulation with the non-ported SPIVC with multi-use blood control septum (Introcan Safety® 3 B Braun), compared to the standard ported SPIVC (Vasofix® Safety B Braun) (P < 0.05). The direct cost analysis, including clinician time, demonstrated that the introduction of SPIVC with multi-use blood control septum could offer time efficiency savings equivalent to a reduction in average cannulation costs by 25%. 82% of users perceived the insertion of SPIVC with multi-use blood control septum to be easy to use; 82% would choose to use it in clinical practice.

Keywords: cannulations; time saving; time efficiency; non-ported cannula; non-ported catheter; safety PIVC; peripheral cannula; peripheral intravenous cannula; cost saving; innovation; blood control septum; medical devices; device costs; clinician time; efficiency savings; UK; United Kingdom; cannulation costs.

DOI: 10.1504/IJHTM.2016.078336

International Journal of Healthcare Technology and Management, 2016 Vol.15 No.3, pp.177 - 193

Received: 20 Dec 2014
Accepted: 22 Nov 2015
Published online: 15 Aug 2016 *

Title: Introduction of a non-ported peripheral intravenous catheter with multi-use blood control septum offers improvements in the overall efficiency of the procedure and is clinically well accepted

Keep up-to-date